Epstein-Barr virus strategy in normal and neoplastic B cells.
Klein
G
G
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.
D000818:Animals; D001402:B-Lymphocytes / Q000382:microbiology*; D002472:Cell Transformation, Viral; D004854:Herpesvirus 4, Human / Q000502:physiology*; D006801:Humans; D009369:Neoplasms / Q000382:microbiology*; D013602:T-Lymphocytes, Cytotoxic / Q000382:microbiology; D017735:Virus Latency